To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.

The bill titled "To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes" was introduced in the 119th Congress as H.R. 8339 on April 16, 2026. The bill's main focus is on improving drug manufacturing amount information reporting under the Federal Food, Drug, and Cosmetic Act, with additional provisions aimed at achieving other goals specified within the bill's text.